![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Found 16 studies with search of: | "Dermatofibrosarcoma" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Imatinib in Dermatofibrosarcoma Protuberans (DFSP)
|
||||
2 | Recruiting |
Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans
|
||||
3 | Recruiting |
A Short Course of Neoadjuvant Gleevec (Imatinib Mesylate) in Dermatofibrosarcoma Protuberans
|
||||
4 | Recruiting |
Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
|
||||
5 | Recruiting |
Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans
|
||||
6 | Active, not recruiting |
Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans (DFSP) or Transformed Fibrosarcomatous DFSP
|
||||
7 | Active, not recruiting |
Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
|
||||
8 | Recruiting |
PET Scan Combined With CT Scan in Predicting Response in Patients Undergoing Chemotherapy and Surgery for Soft Tissue Sarcoma
|
||||
9 | Recruiting |
Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma
|
||||
10 | Active, not recruiting |
AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
|
||||
11 | Recruiting |
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
|
||||
12 | Recruiting |
Monoclonal Antibody IMC-A12 and Doxorubicin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
|
||||
13 | Withdrawn |
Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma
|
||||
14 | Completed |
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
|
||||
15 | Completed |
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
|
||||
16 | Recruiting |
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma
|